Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300 over six years. Read why LGND stock is a Buy.

Martin Shkreli, also known as “Pharma Bro,” has escalated his stand against quantum computing firm IONQ Inc. (NYSE:IONQ), accusing the company of peddling exaggerated capabilities to crypto investors.

Bradley Hope was a financial reporter for The Wall Street Journal based in London. Prior to that, he was a correspondent in New York, covering exchanges and market structure. Before that, he was based ...

More than a decade ago, pharmaceutical executive Martin Shkreli paid $2 million for the only copy of a mysterious Wu-Tang Clan album, which he surrendered to the federal government after his 2017 ...

In a dramatic legal battle with a rare Wu‑Tang album at its center, the infamous “Pharma Bro” Martin Shkreli filed new claims accusing RZA of double‑selling rights to Once Upon a Time in Shaolin.

Martin Shkreli has filed a federal counter-lawsuit against RZA and producer Cilvaringz regarding the ownership of the one-of-a-kind Wu-Tang Clan album The disgraced pharmaceutical executive alleges ...

*Martin Shkreli has escalated his ongoing legal battle over the unique Wu-Tang Clan album “Once Upon a Time in Shaolin” by filing a countersuit that accuses the group’s founder, RZA (Robert Diggs), ...

PARK CITY, Utah — A hip-hop miracle was happening Friday afternoon in a mansion in the mountains of Utah. The sole physical copy of the Wu-Tang Clan’s 31-track double album “Once Upon a Time in ...

Director Joanna Natasegara's doc starts off as a hip-hop Horatio Alger story, then focuses on the 'Once Upon a Time in Shaolin' album that sold as a single copy for $2M to the much-loathed Martin ...